Unpacking the relationship between exercise and amyotrophic lateral sclerosis
Talbot K. and Thompson AG., (2025), Brain
TDP-43 pathology is associated with divergent protein profiles in ALS brain and spinal cord
Feneberg E. et al, (2025), Acta Neuropathologica Communications, 13
Neurodegenerative disease in C9orf72 repeat expansion carriers: population risk and effect of UNC13A.
Gao J. et al, (2025), Brain
A Validated Model to Predict Severe Weight Loss in Amyotrophic Lateral Sclerosis
Lester DG. et al, (2025), Annals of Clinical and Translational Neurology
Extracellular vesicles in TDP-43 proteinopathies: pathogenesis and biomarker potential
Dellar ER. et al, (2025), Molecular Neurodegeneration, 20
Gamma activation spread reflects disease activity in amyotrophic lateral sclerosis
Trubshaw M. et al, (2025), Clinical Neurophysiology, 2110823 - 2110823
Progression and life expectancy in primary lateral sclerosis
Lester DG. et al, (2025), Journal of Neurology, Neurosurgery & Psychiatry
Service evaluation of having an additional CT scan for motor neurone disease patients undergoing a gastrostomy.
Newman J. et al, (2025), Br J Nurs, 34, S4 - S8
Asymmetry in amyotrophic lateral sclerosis: clinical, neuroimaging and histological observations.
Yoganathan K. et al, (2025), Brain
Drug repurposing in amyotrophic lateral sclerosis (ALS)
Carroll E. et al, (2025), Expert Opinion on Drug Discovery, 1 - 18
Elevated Cerebrospinal Fluid Ubiquitin Carboxyl‐Terminal Hydrolase Isozyme L1 in Asymptomatic C9orf72 Hexanucleotide Repeat Expansion Carriers
Dellar ER. et al, (2024), Annals of Neurology
The Basis of Cognitive and Behavioral Dysfunction in Amyotrophic Lateral Sclerosis.
Bampton A. et al, (2024), Brain Behav, 14
Apolipoproteins, lipids, lipid-lowering drugs and risk of amyotrophic lateral sclerosis and frontotemporal dementia: a meta-analysis and Mendelian randomisation study
Chalitsios CV. et al, (2024), Journal of Neurology
Personalised penetrance estimation forC9orf72-related amyotrophic lateral sclerosis and frontotemporal dementia
Douglas AGL. et al, (2024), BMJ Neurology Open, 6, e000792 - e000792
Publisher Correction: The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology.
Benatar M. et al, (2024), Nat Rev Neurol, 20
The Miami Framework for ALS and related neurodegenerative disorders: an integrated view of phenotype and biology.
Benatar M. et al, (2024), Nat Rev Neurol, 20, 364 - 376
The cortical neurophysiological signature of amyotrophic lateral sclerosis
Trubshaw M. et al, (2024), Brain Communications
Venous thromboembolism risk in amyotrophic lateral sclerosis: a hospital record-linkage study.
Goldacre R. et al, (2024), J Neurol Neurosurg Psychiatry
Premorbid brain structure influences risk of amyotrophic lateral sclerosis.
Thompson AG. et al, (2023), J Neurol Neurosurg Psychiatry
Data-independent acquisition proteomics of cerebrospinal fluid implicates endoplasmic reticulum and inflammatory mechanisms in amyotrophic lateral sclerosis
Dellar E. et al, (2023), Journal of Neurochemistry